MFRCX
Price
$52.53
Change
+$0.13 (+0.25%)
Updated
Aug 28 closing price
Net Assets
8.11B
VITSX
Price
$155.84
Change
+$0.56 (+0.36%)
Updated
Aug 28 closing price
Net Assets
1.91T
Interact to see
Advertisement

MFRCX vs VITSX

Header iconMFRCX vs VITSX Comparison
Open Charts MFRCX vs VITSXBanner chart's image
MFS Research C
Price$52.53
Change+$0.13 (+0.25%)
VolumeN/A
Net Assets8.11B
Vanguard Total Stock Market Idx I
Price$155.84
Change+$0.56 (+0.36%)
VolumeN/A
Net Assets1.91T
MFRCX vs VITSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MFRCX vs. VITSX commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MFRCX is a Buy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.91T vs. MFRCX (8.11B). VITSX pays higher dividends than MFRCX: VITSX (1.19) vs MFRCX (0.00). MFRCX was incepted earlier than VITSX: MFRCX (32 years) vs VITSX (28 years). MFRCX (1.52) is less costly to investors than VITSX (0.03). MFRCX is a more actively managed with annual turnover of: 20.00 vs. VITSX (2.00). MFRCX has a lower initial minimum investment than VITSX: MFRCX (1000) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 15.92 vs. MFRCX (2.02). VITSX return over 5 years is better than : 80.23 vs. MFRCX (17.28).
MFRCXVITSXMFRCX / VITSX
Total Expense Ratio1.520.035,067%
Annual Report Gross Expense Ratio1.520.035,067%
Fund Existence32 years28 years-
Gain YTD8.55610.14084%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets8.11B1.91T0%
Annual Yield % from dividends0.001.19-
Returns for 1 year2.0215.9213%
Returns for 3 years17.2058.1530%
Returns for 5 years17.2880.2322%
Returns for 10 years52.26224.1623%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DUOL322.784.85
+1.53%
Duolingo
NBR36.330.14
+0.39%
Nabors Industries Ltd
ATOS0.75-0.01
-0.97%
Atossa Therapeutics
PMCB0.96-0.01
-1.03%
PharmaCyte Biotech
LU2.96-0.06
-1.99%
Lufax Holding Ltd